Challenges and solutions to nicotine replacement therapy access: observations from SCIMITAR+

Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

StandardStandard

Challenges and solutions to nicotine replacement therapy access: observations from SCIMITAR+. / Arundel, Catherine Ellen; Peckham, Emily Jane; Bailey, Della et al.
Yn: BJPsych open, Cyfrol 6, Rhif 6, e120, 01.11.2020.

Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

HarvardHarvard

Arundel, CE, Peckham, EJ, Bailey, D, Crosland, S, Heron, PN & Gilbody, S 2020, 'Challenges and solutions to nicotine replacement therapy access: observations from SCIMITAR+', BJPsych open, cyfrol. 6, rhif 6, e120. https://doi.org/10.1192/bjo.2020.100

APA

Arundel, C. E., Peckham, E. J., Bailey, D., Crosland, S., Heron, P. N., & Gilbody, S. (2020). Challenges and solutions to nicotine replacement therapy access: observations from SCIMITAR+. BJPsych open, 6(6), Erthygl e120. https://doi.org/10.1192/bjo.2020.100

CBE

Arundel CE, Peckham EJ, Bailey D, Crosland S, Heron PN, Gilbody S. 2020. Challenges and solutions to nicotine replacement therapy access: observations from SCIMITAR+. BJPsych open. 6(6):Article e120. https://doi.org/10.1192/bjo.2020.100

MLA

VancouverVancouver

Arundel CE, Peckham EJ, Bailey D, Crosland S, Heron PN, Gilbody S. Challenges and solutions to nicotine replacement therapy access: observations from SCIMITAR+. BJPsych open. 2020 Tach 1;6(6):e120. doi: 10.1192/bjo.2020.100

Author

Arundel, Catherine Ellen ; Peckham, Emily Jane ; Bailey, Della et al. / Challenges and solutions to nicotine replacement therapy access: observations from SCIMITAR+. Yn: BJPsych open. 2020 ; Cyfrol 6, Rhif 6.

RIS

TY - JOUR

T1 - Challenges and solutions to nicotine replacement therapy access: observations from SCIMITAR+

AU - Arundel, Catherine Ellen

AU - Peckham, Emily Jane

AU - Bailey, Della

AU - Crosland, Suzanne

AU - Heron, Paul Nicholas

AU - Gilbody, Simon

PY - 2020/11/1

Y1 - 2020/11/1

N2 - BackgroundGiven, smoking results in poor physical and mental health, reducing tobacco harm is of high importance. Recommendations published by National Institute for Health and Care Excellence to reduce smoking harms included provision of support, use of nicotine containing products and commissioning of smoking cessation services. AimsThis report explores the difficulties in obtaining such support, as observed in a recently conducted randomised controlled trial in patients with severe mental ill health, and outlines suggestions to improve facilitation of provision.MethodsData collected during the Smoking Cessation Intervention for severe Mental Ill Health Trial (SCIMITAR+) trial, was reviewed to identify the difficulties experienced, across the trial, with regards to access and provision of NRT. Actions taken to facilitate access and provision of NRT were collated to outline how provision could be better facilitated.ResultsAccess to nicotine replacements therapy (NRT) varied across study settings and in some instances proved impossible for patients to access. Difficulty in access was irrespective of a diagnosis of severe mental ill health. Where NRT was provided, this was not always provided in accordance with NICE guidelines.ConclusionsAvailability of smoking cessation support, and NRT provision would benefit from being made clearer, simpler and more easily accessible so as to enhance smoking cessation rates.

AB - BackgroundGiven, smoking results in poor physical and mental health, reducing tobacco harm is of high importance. Recommendations published by National Institute for Health and Care Excellence to reduce smoking harms included provision of support, use of nicotine containing products and commissioning of smoking cessation services. AimsThis report explores the difficulties in obtaining such support, as observed in a recently conducted randomised controlled trial in patients with severe mental ill health, and outlines suggestions to improve facilitation of provision.MethodsData collected during the Smoking Cessation Intervention for severe Mental Ill Health Trial (SCIMITAR+) trial, was reviewed to identify the difficulties experienced, across the trial, with regards to access and provision of NRT. Actions taken to facilitate access and provision of NRT were collated to outline how provision could be better facilitated.ResultsAccess to nicotine replacements therapy (NRT) varied across study settings and in some instances proved impossible for patients to access. Difficulty in access was irrespective of a diagnosis of severe mental ill health. Where NRT was provided, this was not always provided in accordance with NICE guidelines.ConclusionsAvailability of smoking cessation support, and NRT provision would benefit from being made clearer, simpler and more easily accessible so as to enhance smoking cessation rates.

U2 - 10.1192/bjo.2020.100

DO - 10.1192/bjo.2020.100

M3 - Article

VL - 6

JO - BJPsych open

JF - BJPsych open

SN - 2056-4724

IS - 6

M1 - e120

ER -